|
Markers of Cognitive Decline During Treatment for Childhood ALL
|
1R21CA187226-01A1
|
$196,122
|
$196,122
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
5R01CA182284-02
|
|
$0
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
6R01CA182284-03
|
$346,525
|
$346,525
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-43S1
|
$199,871
|
$7,995
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-42
|
|
$0
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
6P30CA013330-43
|
$3,696,138
|
$147,846
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
5R01CA164024-03
|
$376,095
|
$376,095
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$63,103
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$2,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$3,661
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-17
|
$2,250,582
|
$270,070
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S1
|
$37,026
|
$370
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S2
|
$49,999
|
$500
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-25
|
$4,878,887
|
$48,789
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cdk5 signaling in ICN1-induced T Cell Leukemogenesis
|
1R21CA181875-01A1
|
$206,843
|
$206,843
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$21,688
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$76,793
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$198,927
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$307,453
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$22,899
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$260,823
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$24,673
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$8,066,901
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
5R01CA165277-04
|
$410,314
|
$410,314
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
5K07CA166177-03
|
$164,937
|
$164,937
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia
|
5K08CA184418-02
|
$169,657
|
$169,657
|
TASIAN, SARAH
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Improving risk allocation and developing novel therapies for children with T-ALL
|
1R01CA193776-01
|
$709,314
|
$709,314
|
TEACHEY, DAVID
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-05
|
$654,642
|
$176,753
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
|
5R01CA172896-03
|
$335,154
|
$335,154
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL
|
5R01CA154471-05
|
$332,000
|
$332,000
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
|
5U01CA183030-02
|
$628,352
|
$628,352
|
LIU, YANG
|
CHILDREN'S RESEARCH INSTITUTE
|
|
A Novel Epigenetic Circuit in Acute Leukemia
|
5R21CA187276-02
|
$203,580
|
$203,580
|
HUANG, GANG
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-05
|
$317,475
|
$317,475
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeting non-classical oncogenes as therapy for T-ALL
|
5R01CA169162-04
|
$332,000
|
$166,000
|
DIACOVO, THOMAS
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S1
|
$120,000
|
$3,600
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S2
|
$60,000
|
$1,800
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S3
|
$125,000
|
$3,750
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-41S4
|
$157,133
|
$4,714
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-41
|
$3,792,720
|
$113,782
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of PHF6 in T-cell acute lymphoblastic leukemia
|
5R01CA155743-05
|
$332,000
|
$332,000
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of ETV6 in T-cell acute lymphoblastic leukemia
|
5R01CA172398-03
|
$332,000
|
$166,000
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of FBXL4 in T-cell Acute Lymphoblastic Leukemia
|
5F30CA174099-03
|
$48,120
|
$24,060
|
HAYDU, JULIE-ERIKA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Functional dissection of oncogenic enhancers
|
1K99CA197869-01
|
$170,856
|
$128,142
|
HERRANZ BENITO, DANIEL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA006516-50S1
|
$122,500
|
$1,225
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S2
|
$50,000
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S3
|
$125,000
|
$1,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S4
|
$200,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-50S5
|
$62,500
|
$625
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-50
|
$11,162,542
|
$111,625
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
Total relevant funding to Childhood Leukemia for this search: $53,575,329
|